Valued at USD 1.49 Bn in 2024, the market is projected to reach USD 2.92 Bn by 2033, growing at a 6.74% CAGR. Europe holds the largest share, while Asia-Pacific grows fastest. The report profiles 20 companies.
The global genetic engineering market was valued at USD 1.49 Bn in 2024 and is projected to reach USD 2.92 Bn by 2033, growing at a CAGR of 6.74%. Europe is the largest regional market and Asia-Pacific is growing fastest.
Global Genetic Engineering Market was valued at USD 1,491.6 Million in 2024 and is expected to reach USD 2,917.2 Million by 2033, at a CAGR of 6.74% during the forecast period 2024 - 2033.
Genetic engineering is the process of directly manipulating an organism's genes. Scientists can insert new genes, remove unwanted ones, or change existing ones. This allows for the creation of organisms with desired traits, like pest-resistant crops or bacteria that produce medicine.
The genetic engineering market focuses on the tools and techniques used in this manipulation. This includes things like enzymes for cutting DNA, genetic material like plasmids, and even software for designing genetic modifications. The market is expected to grow significantly in the coming years, driven by factors like increasing demand for personalized medicine and advancements in gene editing techniques like CRISPR.
Genetic Engineering Market Growth Factors
Increasing Demand for Biopharmaceuticals
The global genetic engineering market is driven by the rising demand for biopharmaceuticals, which are developed using genetically engineered processes. Genetic engineering allows for the production of complex proteins and antibodies used in treating various diseases like cancer, diabetes, and autoimmune disorders.
According to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the global pharmaceutical market was valued at $1.2 trillion in 2023, and biopharmaceuticals accounted for a significant portion of this market. The demand for genetically engineered drugs is expected to grow further due to their effectiveness and specificity in treating diseases.
Technological Advancements in Gene Editing Tools
Advancements in gene editing technologies like CRISPR-Cas9 have significantly propelled the genetic engineering market. CRISPR-Cas9 allows precise and efficient modification of genes, making genetic engineering more accessible and cost-effective.
According to the National Institutes of Health (NIH), the global gene editing market is projected to reach $10.7 billion by 2025. The development of novel gene editing techniques is expected to further drive market growth, enabling researchers to target specific genes with higher accuracy and speed.
Genetic Engineering Market Restraints
Ethical and Regulatory Concerns
One of the significant restraints in the global genetic engineering market is the ethical and regulatory challenges associated with altering genetic material. The debate over gene editing in humans and its potential implications has led to stringent regulations in many countries.
The European Union (EU), for instance, has strict guidelines governing the use of genetically modified organisms (GMOs) in agriculture and research. These regulations can slow down the approval process for genetically engineered products, thereby restraining market growth.
High Cost of Development and Research
The high cost of research and development (R&D) in genetic engineering poses a challenge to market expansion. Developing new gene therapies and biopharmaceuticals requires substantial investment in equipment, personnel, and clinical trials.
According to the Organization for Economic Co-operation and Development (OECD), R&D expenditure in the pharmaceutical industry was over $200 billion in 2022, with a significant portion dedicated to genetic engineering. The high costs associated with bringing genetically engineered products to market can limit investment and hinder market growth.
Genetic Engineering Market Opportunities
Growing Applications in Agriculture
The global genetic engineering market presents significant opportunities in agriculture, particularly in crop improvement and pest resistance. Genetically modified (GM) crops have gained traction in several regions due to their ability to enhance yield, reduce pesticide use, and withstand environmental stress.
The Food and Agriculture Organization (FAO) estimates that over 190 million hectares of land worldwide were planted with GM crops in 2023. The adoption of genetic engineering in agriculture is expected to increase further as farmers seek innovative solutions to improve productivity and sustainability.
Expansion in Personalized Medicine
The trend towards personalized medicine offers promising opportunities for genetic engineering. Personalized therapies, tailored to an individual's genetic makeup, hold immense potential in treating genetic disorders and chronic diseases.
According to the World Health Organization (WHO), the global personalized medicine market is projected to reach $3.2 trillion by 2025. Genetic engineering plays a crucial role in developing personalized treatments, such as gene therapies and cell-based therapies, which can address specific genetic mutations. This growing focus on personalized medicine is likely to drive demand for genetic engineering technologies and products.
Genetic Engineering Market: Segmentation Analysis
The Global Genetic Engineering market is segmented by Product, Devices, techniques, applications and end users.
Based on Product, the Global Genetic Engineering Market is segmented into Biochemical and genetic Markers. Among all these segments Genetic Markers held the highest market share in 2023. Genetic markers play a crucial role in various genetic engineering applications such as identifying genes responsible for diseases or desirable traits.
They are fundamental in research and diagnostic applications. Advances in genomics and personalized medicine are driving the growth of genetic marker technologies for precision medicine and targeted therapies.
Based on Devices, Global Genetic Engineering Market is segmented into PCR, Gene Gun, Gel Assemblies. Among all these segments PCR (Polymerase Chain Reaction) held highest market share in 2023.
PCR is a widely used technique in genetic engineering for amplifying DNA, critical for various applications including diagnostics, forensics, and research. Gene editing tools like CRISPR-Cas9 have seen remarkable growth due to their potential in targeted genome modifications for therapeutic and agricultural purposes.
Based on Techniques, the Global Genetic Engineering Market is segmented into Gene Splicing, Artificial Selection, Recombinant DNA Technology, Synthesizing DNA, Gene Editing, and others. Among all these segments Gene Editing held the highest market share in 2023.
Gene editing technologies (e.g., CRISPR-Cas9) are at the forefront due to their precision and versatility in altering genetic sequences. Gene editing is experiencing rapid growth across various sectors including healthcare (for gene therapy) and agriculture (for crop improvement).
Based on Application, Global Genetic Engineering Market is segmented into Agriculture and medical industries. Among all these segments Agriculture held the highest market share in 2023. Genetic engineering in agriculture is widely adopted for improving crop traits, pest resistance, and overall yield.
Applications in medical industrial sectors, especially in gene therapy and personalized medicine, are rapidly expanding due to advancements in genetic technologies.
Based on End-User, the Global Genetic Engineering Market is segmented into Biotechnology Companies, Pharmaceutical Manufacturers, Academic and Research Institutions, and others. Among all these segments Biotechnology Companies held the highest market share in 2023.
Biotech firms are heavily invested in genetic engineering for drug development, diagnostics, and agricultural biotechnology. With increased research funding and collaborations, academic and research institutions are driving innovation in genetic engineering techniques and applications.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 1,491.6 Million |
| Projected Market Size in 2033 | USD 2,917.2 Million |
| Market Size in 2023 | USD 1,400 Million |
| CAGR Growth Rate | 6.74% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Product, Devices, Techniques, Application, End-User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Genetic Engineering Market: Regional Analysis
North America is the leading region in the global genetic engineering market. This is primarily due to several factors. Firstly, North America, particularly the United States, houses some of the world's largest biotechnology and pharmaceutical companies that heavily invest in genetic engineering research and development.
The region benefits from a robust ecosystem of academic institutions, research centers, and venture capital funding, fostering innovation in genetic technologies. Additionally, favorable regulatory frameworks and strong intellectual property protection encourage industry growth and investment.
The presence of sophisticated healthcare infrastructure and high adoption rates of advanced medical technologies further drive the genetic engineering market in North America.
Asia Pacific is emerging as the fastest-growing region in the global genetic engineering market. Countries like China, India, Japan, and South Korea are witnessing rapid growth in the biotechnology and genetic engineering sectors.
The Asia Pacific region offers significant growth opportunities due to its large population base, increasing healthcare expenditure, and rising awareness about personalized medicine and genetic therapies. Furthermore, government initiatives supporting biotechnology research and development, coupled with a growing focus on precision medicine and genomics, are propelling the genetic engineering market in this region.
Lower operating costs and a growing pool of skilled scientific talent also contribute to the attractiveness of Asia Pacific for genetic engineering companies.
In conclusion, while North America remains the leading region in the global genetic engineering market due to its established industry ecosystem and technological advancements, the Asia Pacific region is experiencing rapid growth fueled by favorable demographics, increasing investments, and supportive government policies.
Both regions offer distinct advantages and opportunities for genetic engineering companies, with North America leading in terms of market size and maturity, and Asia Pacific leading in terms of growth potential and emerging market dynamics.
Source: Custom Market Insights analysis.
To learn more about this report - request a sample report PDF
Genetic Engineering Market: Recent Developments
List of the prominent players in the Genetic Engineering Market:
These key players are adopting various organic and inorganic growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.
The Genetic Engineering Market is segmented as follows:
By Product
By Devices
By Techniques
By Application
By End-User
Regional Coverage:
North America
Europe
Asia Pacific
The Middle East & Africa
Latin America
Updated: January 2026 · Formats: PDF, Excel, PPT
The Increasing Demand for Biopharmaceuticals is major driver in global Genetic Engineering market.
The "Agriculture" had the largest share in the global market for Genetic Engineering.
The "Biochemical" category dominated the market in 2023.
The key players in the market are Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), GenScript (China), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), Tecan Life Sciences (Switzerland), Sangamo Therapeutics (US), Editas Medicine (US), CRISPR Therapeutics AG (Switzerland), Precision Biosciences (US), Cellectis S.A. (France), Intellia Therapeutics (US), Bluebird Bio Inc. (US), Regeneron Pharmaceuticals (US), AMSBIO (England), Creative Biogene (US), Synthego Corporation (US), Beam Therapeutics Inc. (US), Caribou Biosciences Inc. (US), Others.
"North America" had the largest share in the Genetic Engineering Market.
The global market is projected to grow at a CAGR of 6.74% during the forecast period, 2024-2033.
The Genetic Engineering Market size was valued at USD 1,491.6 Million in 2024.
Author · Sr. Research Analyst
Ayush Kadam is a Senior Market Research Analyst at Custom Market Insights, with over seven years of experience in syndicated and custom market research. He specializes in market sizing, competitive intelligence, industry trends, forecasting, and strategic insights, helping clients turn complex data into actionable business decisions.
Buy individual chapters for $490 each: 10 chapters available, from Executive Summary to Company Profiles.
Get the full report structure, sample pages and data tables in the free sample.
Download free sampleGet the full report structure, sample pages and data tables in the free sample.
Download free sampleGet the full report structure, sample pages and data tables in the free sample.
Download free sample